SIC 2834 – Pharmaceutical Preparations
Valuation | |
---|---|
Market Cap ($M) | 265,066.51 |
Enterprise Value ($M) | 332,647.51 |
Book Value ($M) | 15,436.00 |
Book Value / Share | 8.74 |
Price / Book | 17.17 |
NCAV ($M) | -100,388.00 |
NCAV / Share | -56.81 |
Price / NCAV | -2.64 |
Profitability (mra) | |
---|---|
Return on Invested Capital (ROIC) | 0.14 |
Return on Assets (ROA) | 0.08 |
Return on Equity (ROE) | 0.91 |
Liquidity (mrq) | |
---|---|
Quick Ratio | 0.71 |
Current Ratio | 0.82 |
Balance Sheet (mrq) ($M) | |
---|---|
Current Assets | 26,509.00 |
Assets | 143,211.00 |
Liabilities | 126,897.00 |
Debt | n/a |
Equity | n/a |
Income Statement (mra) ($M) | |
---|---|
Revenue | 56,197.00 |
Operating Income | 19,537.00 |
Net Income | 11,542.00 |
Earnings Per Share Diluted | n/a |
Earnings Per Share Basic | n/a |
Cash Flow Statement (mra) ($M) | |
---|---|
Cash From Operations | 22,777.00 |
Cash from Investing | -2,344.00 |
Cash from Financing | -19,039.00 |
(click for more detail) |
File Date | Form | Activist 13D/G Investors | Ownership (%) |
Change (%) |
---|---|---|---|---|
13G/A | Vanguard Group Inc | 8.28 | 2.63 | |
13G/A | BlackRock Inc. | 7.30 | 3.03 |
Top 13F Investors | Shares (1000) |
Change (%) |
Value ($1000) |
Change (%) |
---|---|---|---|---|
(click for more detail) |
Date | Insider Trades | Code | Shares | Value |
---|---|---|---|---|
(click for more detail) |
Short Volume | |||
---|---|---|---|
Market Date | Short Volume | Total Volume | Short Volume Ratio |
711,655 | 6,365,002 | 11.18 | |
484,276 | 4,811,441 | 10.07 | |
495,129 | 3,999,692 | 12.38 | |
361,388 | 5,260,488 | 6.87 | |
488,159 | 5,368,185 | 9.09 | |
(click for more detail) |
|||
(click for list of largest short owners) |
Similar Companies | |
---|---|
ABT – Abbott Laboratories | ADCT – Adc Telecommunications Inc |
Financial data and stock pages provided by
Fintel.io